AU2002357613A1 - Method of detecting antitelomerase antibody - Google Patents
Method of detecting antitelomerase antibodyInfo
- Publication number
- AU2002357613A1 AU2002357613A1 AU2002357613A AU2002357613A AU2002357613A1 AU 2002357613 A1 AU2002357613 A1 AU 2002357613A1 AU 2002357613 A AU2002357613 A AU 2002357613A AU 2002357613 A AU2002357613 A AU 2002357613A AU 2002357613 A1 AU2002357613 A1 AU 2002357613A1
- Authority
- AU
- Australia
- Prior art keywords
- antitelomerase
- antibody
- detecting
- detecting antitelomerase
- antitelomerase antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/91245—Nucleotidyltransferases (2.7.7)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Biophysics (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001390050 | 2001-12-21 | ||
| JP2001/390050 | 2001-12-21 | ||
| PCT/JP2002/013310 WO2003054545A1 (en) | 2001-12-21 | 2002-12-19 | Method of detecting antitelomerase antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002357613A1 true AU2002357613A1 (en) | 2003-07-09 |
Family
ID=19188330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002357613A Abandoned AU2002357613A1 (en) | 2001-12-21 | 2002-12-19 | Method of detecting antitelomerase antibody |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2003054545A1 (en) |
| AU (1) | AU2002357613A1 (en) |
| WO (1) | WO2003054545A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| WO1998014593A2 (en) * | 1996-10-01 | 1998-04-09 | Geron Corporation | Human telomerase catalytic subunit |
| JPH11276182A (en) * | 1997-12-26 | 1999-10-12 | Chugai Pharmaceut Co Ltd | Novel gene with reverse transcriptase motif |
-
2002
- 2002-12-19 AU AU2002357613A patent/AU2002357613A1/en not_active Abandoned
- 2002-12-19 JP JP2003555207A patent/JPWO2003054545A1/en active Pending
- 2002-12-19 WO PCT/JP2002/013310 patent/WO2003054545A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003054545A1 (en) | 2003-07-03 |
| JPWO2003054545A1 (en) | 2005-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001294175A1 (en) | Method of purifying antibody | |
| EP1271099A3 (en) | Method and arrangement for determining movement | |
| AU2002346008A1 (en) | Method for detection of melanoma | |
| AU2002367180A1 (en) | Concentration measuring method | |
| AU2003242024A1 (en) | Method of constructing antibody | |
| AU2002316137A1 (en) | Method of determining protein interaction inhibitors | |
| AU2002256895A1 (en) | Anti-TRAIL-R antibodies | |
| AU2002302243A1 (en) | Method for determination of co-occurences of attributes | |
| AU2001251414A1 (en) | Method of detecting carcinomas | |
| AU2002249206A1 (en) | Device and method for detecting the presence of an analyte | |
| AU2002323600A1 (en) | Method for detecting sepsis | |
| AU2002345204A1 (en) | Method for determining chromatin structure | |
| AU2002317672A1 (en) | Method for the biochemical detection of analytes | |
| AU2001267922A1 (en) | Method of assaying the function of fc fragment of antibody | |
| AU2002330561A1 (en) | Reagent and method for perfluoroalkylation | |
| AU2002351532A1 (en) | Method of sampling | |
| AU2001246862A1 (en) | Method of detecting cancer | |
| AU2002357613A1 (en) | Method of detecting antitelomerase antibody | |
| AU2002367198A1 (en) | Method of detecting defect of glass | |
| AU2001253092A1 (en) | Method for detection of truncated proteins | |
| AU2002222647A1 (en) | Antibody specific for detection of bradeion | |
| AU2002216423A1 (en) | Method of assaying agglutination reaction | |
| AU2002249588A1 (en) | Method of quantifying antigen expression | |
| HK1058967A (en) | Detection of analytes | |
| AUPR921901A0 (en) | Determining antibody specificity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |